Stephanie Shafer, MSN, ANP-BC, PMHNP-BC, will deliver an advanced and updated review of stimulant (e.g., methylphenidate, amphetamines) and non-stimulant (e.g., atomoxetine, guanfacine) medications, with a particular focus on understanding the mechanisms of action, how they differ, and how one might synergistically compliment another. Learn how these medications affect the brain’s chemistry and function to alleviate ADHD symptoms, allowing for a deeper appreciation of their therapeutic potential. Central to the discussion will be the identification of presenting symptomatology and the evaluating of treatment outcomes. This focus will provide the knowledge and skills needed to adeptly navigate the evolving landscape of ADHD management.
By the talk’s conclusion, you will possess a robust understanding of ADHD’s neurobiological basis, as well as a comprehensive knowledge of the mechanisms by which available medications act. Deliver personalizing care for patients with ADHD to enhance their quality of life and daily functioning to the future.